Aspen Aerogels Q3 revenue and Adjusted EBITDA top outlook as segments rebound
Aspen Aerogels reported Q3 revenue of $85.2M and Adjusted EBITDA of $19.8M, both above outlook, according to TradingView, with Q4 guidance set at $60–75M.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, Aspen Aerogels posted third-quarter revenue of $85.2M and Adjusted EBITDA of $19.8M. Both figures came in above the company's outlook, and the Thermal Barrier and Energy Industrial segments both grew from the previous quarter.
For the fourth quarter, the company guides to revenue of $60–75M. It lists the restoration of its East Providence facility and market demand among its key uncertainties.
why it matters
Beating expectations on both revenue and EBITDA suggests operating momentum is recovering. However, the narrow fourth-quarter guidance range and risks around the East Providence facility leave open questions about the next period.
market impact
Aspen Aerogels shares: results above outlook support interest in the stock
- Aspen Aerogels shares pressure up — results above outlook on revenue and EBITDA support the stock
tags
instruments
sources
- ASPN: Q3 revenue and Adjusted EBITDA beat outlook as both segments rebounded — TradingView, 5 November 2026 at 11:41 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗